The FDA made headlines Monday morning (Aug. 23) after announcing full approval of the Pfizer-Biontech COVID-19 vaccine for people ages 16 and older. This is the first COVID-19 vaccine to achieve full approval from the FDA.
“Based on the longer-term follow-up data that we submitted, today’s approval for those aged 16 and over affirms the efficacy and safety profile of our vaccine at a time when it is urgently needed,” said Albert Bourla, Chair and CEO of Pfzier. “I am hopeful this approval will help increase confidence in our vaccine, as vaccination remains the best tool we have to help protect lives and achieve herd immunity. Hundreds of millions of doses of our vaccine already have been administered in the U.S. since December 2020, and we look forward to continuing to work with the U.S. government to reach more Americans,” Bourla continued.
Dr. Alok Patel, physician at Stanford Children’s Health, stopped by ABC News to celebrate what he calls, “optimistic news.”